IBDEI21X ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34803,1,4,0)
 ;;=4^R94.4
 ;;^UTILITY(U,$J,358.3,34803,2)
 ;;=^5019741
 ;;^UTILITY(U,$J,358.3,34804,0)
 ;;=R94.5^^131^1692^17
 ;;^UTILITY(U,$J,358.3,34804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34804,1,3,0)
 ;;=3^Abnormal Liver Function Studies
 ;;^UTILITY(U,$J,358.3,34804,1,4,0)
 ;;=4^R94.5
 ;;^UTILITY(U,$J,358.3,34804,2)
 ;;=^5019742
 ;;^UTILITY(U,$J,358.3,34805,0)
 ;;=R94.6^^131^1692^21
 ;;^UTILITY(U,$J,358.3,34805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34805,1,3,0)
 ;;=3^Abnormal Thyroid Function Studies
 ;;^UTILITY(U,$J,358.3,34805,1,4,0)
 ;;=4^R94.6
 ;;^UTILITY(U,$J,358.3,34805,2)
 ;;=^5019743
 ;;^UTILITY(U,$J,358.3,34806,0)
 ;;=R94.7^^131^1692^5
 ;;^UTILITY(U,$J,358.3,34806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34806,1,3,0)
 ;;=3^Abnormal Endocrine Function Sutdies NEC
 ;;^UTILITY(U,$J,358.3,34806,1,4,0)
 ;;=4^R94.7
 ;;^UTILITY(U,$J,358.3,34806,2)
 ;;=^5019744
 ;;^UTILITY(U,$J,358.3,34807,0)
 ;;=R94.31^^131^1692^4
 ;;^UTILITY(U,$J,358.3,34807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34807,1,3,0)
 ;;=3^Abnormal EKG
 ;;^UTILITY(U,$J,358.3,34807,1,4,0)
 ;;=4^R94.31
 ;;^UTILITY(U,$J,358.3,34807,2)
 ;;=^5019739
 ;;^UTILITY(U,$J,358.3,34808,0)
 ;;=R97.0^^131^1692^67
 ;;^UTILITY(U,$J,358.3,34808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34808,1,3,0)
 ;;=3^Elevated Carcinoembryonic Antigen 
 ;;^UTILITY(U,$J,358.3,34808,1,4,0)
 ;;=4^R97.0
 ;;^UTILITY(U,$J,358.3,34808,2)
 ;;=^5019746
 ;;^UTILITY(U,$J,358.3,34809,0)
 ;;=R97.1^^131^1692^66
 ;;^UTILITY(U,$J,358.3,34809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34809,1,3,0)
 ;;=3^Elevated Cancer Antigen 125
 ;;^UTILITY(U,$J,358.3,34809,1,4,0)
 ;;=4^R97.1
 ;;^UTILITY(U,$J,358.3,34809,2)
 ;;=^5019747
 ;;^UTILITY(U,$J,358.3,34810,0)
 ;;=R97.2^^131^1692^68
 ;;^UTILITY(U,$J,358.3,34810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34810,1,3,0)
 ;;=3^Elevated PSA
 ;;^UTILITY(U,$J,358.3,34810,1,4,0)
 ;;=4^R97.2
 ;;^UTILITY(U,$J,358.3,34810,2)
 ;;=^5019748
 ;;^UTILITY(U,$J,358.3,34811,0)
 ;;=R97.8^^131^1692^22
 ;;^UTILITY(U,$J,358.3,34811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34811,1,3,0)
 ;;=3^Abnormal Tumor Markers NEC
 ;;^UTILITY(U,$J,358.3,34811,1,4,0)
 ;;=4^R97.8
 ;;^UTILITY(U,$J,358.3,34811,2)
 ;;=^5019749
 ;;^UTILITY(U,$J,358.3,34812,0)
 ;;=R93.8^^131^1692^12
 ;;^UTILITY(U,$J,358.3,34812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34812,1,3,0)
 ;;=3^Abnormal Findings on Dx Imaging of Body Structures
 ;;^UTILITY(U,$J,358.3,34812,1,4,0)
 ;;=4^R93.8
 ;;^UTILITY(U,$J,358.3,34812,2)
 ;;=^5019721
 ;;^UTILITY(U,$J,358.3,34813,0)
 ;;=R93.1^^131^1692^14
 ;;^UTILITY(U,$J,358.3,34813,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34813,1,3,0)
 ;;=3^Abnormal Findings on Dx Imaging of Heart/Cor Circ
 ;;^UTILITY(U,$J,358.3,34813,1,4,0)
 ;;=4^R93.1
 ;;^UTILITY(U,$J,358.3,34813,2)
 ;;=^5019714
 ;;^UTILITY(U,$J,358.3,34814,0)
 ;;=R68.83^^131^1692^48
 ;;^UTILITY(U,$J,358.3,34814,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34814,1,3,0)
 ;;=3^Chills w/o Fever
 ;;^UTILITY(U,$J,358.3,34814,1,4,0)
 ;;=4^R68.83
 ;;^UTILITY(U,$J,358.3,34814,2)
 ;;=^5019555
 ;;^UTILITY(U,$J,358.3,34815,0)
 ;;=R68.2^^131^1692^62
 ;;^UTILITY(U,$J,358.3,34815,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34815,1,3,0)
 ;;=3^Dry Mouth,Unspec
 ;;^UTILITY(U,$J,358.3,34815,1,4,0)
 ;;=4^R68.2
 ;;^UTILITY(U,$J,358.3,34815,2)
 ;;=^5019552
 ;;^UTILITY(U,$J,358.3,34816,0)
 ;;=R09.02^^131^1692^88
 ;;^UTILITY(U,$J,358.3,34816,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34816,1,3,0)
 ;;=3^Hypoxemia
 ;;^UTILITY(U,$J,358.3,34816,1,4,0)
 ;;=4^R09.02
 ;;^UTILITY(U,$J,358.3,34816,2)
 ;;=^332831
